Back to Search Start Over

Exosomal integrins in tumor progression, treatment and clinical prediction (Review).

Authors :
Shen YQ
Sun L
Wang SM
Zheng XY
Xu R
Source :
International journal of oncology [Int J Oncol] 2024 Dec; Vol. 65 (6). Date of Electronic Publication: 2024 Nov 14.
Publication Year :
2024

Abstract

Integrins are a large family of cell adhesion molecules involved in tumor cell differentiation, migration, proliferation and neovascularization. Tumor cell‑derived exosomes carry a large number of integrins, which are closely associated with tumor progression. As crucial mediators of intercellular communication, exosomal integrins have gained attention in the field of cancer biology. The present review examined the regulatory mechanisms of exosomal integrins in tumor cell proliferation, migration and invasion, and emphasized their notable roles in tumor initiation and progression. The potential of exosomal integrins as drug delivery systems in cancer treatment was explored. Additionally, the potential of exosomal integrins in clinical tumor prediction was considered, while summarizing their applications in diagnosis, prognosis assessment and treatment response prediction. Thus, the present review aimed to provide guidance and insights for future basic research and the clinical translation of exosomal integrins. The study of exosomal integrins is poised to offer new perspectives and methods for precise cancer treatment and clinical prediction.

Details

Language :
English
ISSN :
1791-2423
Volume :
65
Issue :
6
Database :
MEDLINE
Journal :
International journal of oncology
Publication Type :
Academic Journal
Accession number :
39540373
Full Text :
https://doi.org/10.3892/ijo.2024.5706